Impaired Endothelial Integrity in Patients With Embolic Stroke of Undetermined Source (ESUS)
NCT ID: NCT03609437
Last Updated: 2025-07-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
215 participants
OBSERVATIONAL
2018-01-01
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Registry Study for the Observation of Patients With ESUS/Cryptogenic Stroke
NCT03820375
Transesophageal Echocardiography in Embolic Stroke of Undetermined Source
NCT03107637
Identification of New Markers of Atrial Myopathy in Patients With Embolic Stroke of Undetermined Source (ESUS) From MRI 4D Data
NCT04717843
Young ESUS Patient Registry
NCT03185520
Embolic Signals Detection Study (Esds) in Candidates for Surgical Carotid Revascularisation
NCT05134493
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In participants (patients and controls) the investigators plan to measure and compare: a) perfused boundary region (PBR) of the sublingual arterial microvessels (range 5-25 micrometers), a marker inversely related with glycocalyx thickness, b) pulse wave velocity (PWV), central systolic blood pressure (cSBP) and augmentation index (AIx), c) LV Global Longitudinal strain (GLS), d) LA volume and strain using speckle-tracking strain imaging, e) Malondialdehyde (MDA), as an oxidative stress marker.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ESUS patients
Acute ischemic stroke patients satisfying embolic stroke of undetermined source (ESUS) diagnostic criteria.
No interventions assigned to this group
Controls
Healthy volunteers (colleagues, friends, relatives and others).
No interventions assigned to this group
Lacunar stroke patients
Acute ischemic stroke patients satisfying lacunar stroke diagnostic criteria
No interventions assigned to this group
Cardioembolic stroke patients
Acute ischemic stroke patients satisfying cardioembolic stroke diagnostic criteria
No interventions assigned to this group
Atherosclerotic stroke patients
Acute ischemic stroke patients satisfying atherosclerotic stroke diagnostic criteria
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. the presence of stroke of other determined etiology,
3. the history of previous Ischemic stroke and/or Myocardial Infarction (MI),
4. hypercoagulable state,
5. active malignancy
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Athens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ignatios Ikonomidis
Dr Ignatios Ikonomidis,MD,PhD,FESC Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ignatios Ikonomidis
Role: PRINCIPAL_INVESTIGATOR
University of Athens
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Konstantinos Katogiannis
Athens, Attica, Greece
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ikonomidis I, Frogoudaki A, Vrettou AR, Andreou I, Palaiodimou L, Katogiannis K, Liantinioti C, Vlastos D, Zervas P, Varoudi M, Lambadiari V, Triantafyllidi H, Pavlidis G, Efentakis P, Tsoumani M, Tsantes AE, Parissis J, Revela I, Andreadou I, Tsivgoulis G. Impaired Arterial Elastic Properties and Endothelial Glycocalyx in Patients with Embolic Stroke of Undetermined Source. Thromb Haemost. 2019 Nov;119(11):1860-1868. doi: 10.1055/s-0039-1694752. Epub 2019 Aug 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
esus-endothelium-attikon
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.